S. Selvaratnam et al. / Tetrahedron Letters 50 (2009) 1125–1127
1127
some of the examples above, excellent conversion to the spiroketals
is achieved with short reaction times and low catalyst loadings.
Work is currently underway in our laboratories to develop chiral
metal catalysts for the enantioselective synthesis of spiroketals.
X
CF3
CF3
M
B
BARF =
4
Acknowledgments
1: M = Ir, X = BARF
2: M =Rh, X = BARF
3: M =Rh, X = PF6
Financial support from the Agency for Science, Technology and
*
Research (A STAR) in the form of an institutional Grant is gratefully
Encouraged by these results, the transformation of a range of al-
kyl and aryl internal alkyne diols was examined (Table 1). The data
in Table 1 demonstrate the versatility of the spirocyclization reac-
tion as [4.4], [4.5], [5.5], and [4.6] spiroketal motifs can be synthe-
sized from appropriate precursors. In all cases, the iridium catalyst
1 was superior in promoting the double hydroalkoxylation of the
alkyne diols as compared to its rhodium analogue 2.
acknowledged. This work was also supported by the Australian Re-
search Council and the University of New South Wales. J.H.H.Ho is
grateful to the University of New South Wales for a University
International Postgraduate Award (UIPA).
References and notes
1. Perron, F.; Albizati, K. F. Chem. Rev. 1989, 89, 1617.
It was noted that the efficiency of the Rh(I) complex 2 in cata-
lyzing the spirocyclization reaction decreased with increasing
chain length and/or bulkiness of the substituent present on the al-
kyne (substrates 5–7). For complete consumption of the starting
alkyne diols, reaction times of up to 24 h were frequently required.
However, when the counterion of the Rh complex was replaced
with the more coordinating counterion PF6À, complete conversions
to products were obtained in much shorter reaction times (catalyst
2. Hintzer, K.; Weber, R.; Schurig, V. Tetrahedron Lett. 1981, 22, 55.
3. (a) Boivin, T. L. B. Tetrahedron 1987, 43, 3309; (b) Brasholz, M.; Sörgel, S.; Azap,
C.; Reibig, H.-U. Eur. J. Org. Chem. 2007, 3801.
4. (a) Yeung, K.-S.; Paterson, I. Chem. Rev. 2005, 105, 4237; (b) Brimble, M. A.; Liu,
Y.-C.; Trzoss, M. Synthesis 2007, 1392.
5. (a) Doubsky´, J.; Streinz, L.; Šaman, D.; Zedník, J.; Koutek, B. Org. Lett. 2004, 6,
4909; (b) Mead, K. T.; Brewer, B. N. Curr. Org. Chem. 2003, 7, 227.
6. (a) Tursun, A.; Canet, I.; Aboab, B.; Sinibaldi, M.-E. Tetrahedron Lett. 2005, 46,
2291; (b) de Greef, M.; Zard, S. Z. Org. Lett. 2007, 9, 1773; (c) Sommer, S.; Kühn,
M.; Waldmann, H. Adv. Synth. Catal. 2008, 350, 1736.
7. (a) Utimoto, K. Pure Appl. Chem. 1983, 55, 1845; (b) Patil, N. T.; Lutete, L. M.;
Wu, H.; Pahadi, N. K.; Gridnev, I. D.; Yamamoto, Y. J. Org. Chem. 2006, 71, 4270;
(c) Trost, B. M.; Weiss, A. H. Angew. Chem., Int. Ed. 2007, 46, 7664.
8. Liu, B.; de Brabander, J. K. Org. Lett. 2006, 8, 4907.
9. Zhang, Y.; Xue, J.; Xin, Z.; Xie, Z.; Li, Y. Synlett 2008, 940.
10. Genin, E.; Antoniotti, S.; Michelet, V.; Genet, J.-P. Angew. Chem., Int. Ed. 2005, 44,
4949.
11. Trost, B. M.; Rhee, Y. H. J. Am. Chem. Soc. 2003, 125, 7482.
12. (a) Messerle, B. A.; Vuong, K. Q. Pure Appl. Chem. 2006, 78, 385; (b) Messerle, B.
A.; Vuong, K. Q. Organometallics 2007, 26, 3031; (c) Elgafi, S.; Field, L. D.;
Messerle, B. A. J. Organomet. Chem. 2000, 607, 97.
13. (a) Dervisi, A.; Carcedo, C.; Ooi, L.-L. Adv. Synth. Catal. 2006, 348, 175; (b)
Guzel, B.; Omary, M. A.; Fackler, J. P., Jr.; Akgerman, A. Inorg. Chim. Acta
2001, 325, 45.
À
2 vs 3). The increased efficiency of the PF6 counterion could be
attributed to the stabilization of the reactive intermediates by
À
À
the PF6 anion or the enhanced stability of PF6 relative to the
BARF- counterion.
The cyclization of the unsubstituted alkyne diol, 4-nonyne-1,9-
diol (8) resulted in the formation of two regioisomers. With the
Ir(I) catalyst (1), [5.5] and [4.6] spiroketals, 15 and 16, were formed
in the ratio 3.1:1 within 16 h. The reaction was muchslower with the
Rh(I) catalyst 3. This reaction went to completion in 42 h, and the
products 15 and 16 were formed in a 3.4:1 ratio. By comparison, in
previous reports of the spiroketalization of 8 using PdCl2 as a cata-
lyst, the [4.6] spiroketal 16 was obtained selectively.7a de Brabander
et al.8 in turn found that the PdCl2-catalyzed cyclization of 8 resulted
in a 1:2.5 mixture of spiroketals 15 and 16. It is noteworthy that
these observations suggest that Pd(II) catalysts favor the formation
of the [4.6] spiroketal while the use of Ir(I) and Rh(I) catalysts 1
and 3, under our conditions, favors the [5.5] spiroketal.
The transition metal-catalyzed cyclization of 5-(2-(hydroxy-
methyl)phenyl)pent-4-yn-1-ol (9) led to the formation of the two
possible regioisomeric spiroketals 17 and 18. With the Ir catalyst
1 under our reaction conditions, almost equal amounts of 17 and
18 were formed. This is in contrast to the observations of Crabtree
et al.18 where the use of an Ir(III) hydride catalyst favored the for-
mation of spiroketal 18 over 17 in a ratio of 11:1. In our studies,
treatment of diol 9 with the Rh catalysts (2 or 3) gave a mixture
of spiroketals 17 and 18 in a 1:2.3 or 1:2.5 ratio. In comparison,
the treatment of substrate 9 with Ir(I) and Rh(I) catalysts bearing
N-donor ligands was recently reported to give the spiroketals 17
and 18 in 1:1 and 1.7:1 ratios, respectively.12
The substrate scope was also extended to diaryl alkyne diols.
Cyclization of the aromatic substrate 10 to spiroketal 19 proceeded
smoothly with all three catalysts 1–3. It should be noted that the
reaction times for the conversion of substrates 9 and 10 with the Ir
catalyst 1 are very much shorter than the corresponding reactions
with the Ir catalyst bearing N-donor ligands. The presence of N-do-
nor ligands on the Ir retards the hydroxyalkoxylation reaction.
In summary, we have demonstrated that easily prepared Ir(I)
and Rh(I) complexes efficiently promote the double cyclization
reaction of a range of aliphatic and aromatic alkyne diols. The ease
of preparation of these substrates combined with the simplicity of
the metal complexes provides a straightforward and valuable route
to the preparation of biologically active spiroketals. In addition, in
14. Lee, Y. B.; Folk, J. E. Bioorg. Med. Chem. 1998, 6, 253.
15.
A typical procedure is as follows: All the metal-catalyzed reactions were
performed on small scale in NMR tubes fitted with a concentric Teflon Young
top with (CDCl2)2 as solvent. All additions and weighings were carried out in a
glove box. In a typical experiment, the substrate (20–30 mg) was weighed into
an NMR tube and diluted with about 0.2 mL of solvent. The catalyst (1–
12 lmol, 0.5–5 mol %) was then weighed into a sample bottle and dissolved in
the same solvent (0.4 mL). It was then transferred to the NMR tube using a
syringe. The catalytic reaction was performed at elevated temperature (90 °C)
by heating in an oil bath. The conversion of starting material to product was
determined by integration of selected 1H NMR signals of the product relative to
selected 1H NMR signals of the substrate. The diastereomeric ratio of the
products was determined by 1H NMR spectroscopy, and GC analysis, in
comparison with data reported in the literature.
16. General procedure for the isolation of product from the NMR-scale reaction in
(CDCl2)2: Upon completion of the reaction, as determined by 1H NMR
spectroscopy, the content of the tube was poured into a small beaker, the
NMR tube rinsed with diethyl ether and the mixture was diluted with n-
pentane. The resulting solution was passed through a short pad of silica. The
solvent was removed in vacuo and the product characterized by 1H NMR, 13C
NMR spectroscopy and GC–MS (HP-5 column) analysis. New compounds have
been characterized.
17. Spectral data for selected compounds: (a) 1: reddish-brown solid, 1H NMR
(400 MHz, CD2Cl2) d 2.35 (m, 16H, CH2 of COD), 5.02 (br s, 8H, CH of COD), 7.48
(br s, 4H of BARF), 7.64 (m, 8H of BARF); 19F NMR (CD2Cl2) d À63.5 (s); Anal.
Calcd for C48H36IrBF24Á0.5CH2Cl2: C, 44.31; H, 2.82. Found: C, 44.69; H, 2.75. (b)
Compound 6: colorless oil, 1H (400 MHz, CDCl3) d 1.66 (m, 2H, CH2), 2.23 (m,
2H, CH2), 2.53 (m, 2H, CH2), 3.65 (t, J = 6 Hz, 2H, OCH2), 4.76 (dt, J = 6.2 Hz,
1.6 Hz, 1H, CH), 7.30 (m, 5H, Ar-H); 13C (100 MHz, CDCl3) d 15.5 (CH2), 29.9
(CH2), 31.3 (CH2), 61.9 (OCH2), 72.6 (CH), 76.7 („C), 82.5 (C„), 125.7 (Ar-CH),
127.8 (Ar-CH), 128.4 (Ar-CH), 142.8 (quart. C). HRMS (ESI): m/z calcd for
C13H16O2Na (M+Na)+ 227.10425, found 227.10512. (c) Compound 7: colorless
oil, 1H (400 MHz, CDCl3) d 1.57 (m, 4H, CH2 Â 2), 2.17 (m, 2H, CH2), 2.55 (m, 2H,
CH2), 3.60 (t, J = 6.2 Hz, 2H, OCH2), 4.70 (dt, J = 5.2 Hz, 2.4 Hz, 1H, CH), 7.28 (m,
5H, Ar-H); 13C (100 MHz, CDCl3) d 18.5 (CH2), 25.1 (CH2), 29.9 (CH2), 31.8 (CH2),
62.4 (OCH2), 72.6 (CH), 76.5 („C–), 83.1 (–C„), 125.8 (Ar-CH), 127.8 (Ar-CH),
128.4 (Ar-CH), 142.8 (quart. C). HRMS (ESI): m/z calcd for C14H18O2Na (M+Na)+
241.11990, found 241.12101. (d) Compounds 9–10 and 17–19: spectral data
have been reported in Refs. 12a and b.
18. Li, X.; Chianese, A. R.; Vogel, T.; Crabtree, R. H. Org. Lett. 2005, 7, 5437.